Psychiatry and Neurology, Neurology · Centralia, IL
NPI
1508867300
Since 2005
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
1007 Ml King Dr, Suite 1
Centralia, IL, 62801
Phone (618) 533-9577
Groups this clinician bills Medicare through
Medicare paid, 2024
$317K
4,457 services
Medicare patients, 2024
870
Average age 73
Drug cost, 2024
$1.3M
8,053 prescriptions
Company payments, 2025
$1,214
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Syed A Shah was code 99232 (hospital e&m - subsequent), 1,917 times for 284 patients. In total Syed A Shah billed 4,457 services in 21 codes, and Medicare paid $317K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-09-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 1,917 | 284 | $56.26 | $108K |
| 99214 Office E&M - Established | Office | 1,288 | 495 | $80.73 | $104K |
| 99222 Hospital E&M - Initial | Facility | 450 | 375 | $93.67 | $42K |
| 99309 SNF E&M | Office | 178 | 51 | $71.46 | $13K |
| 99239 Hospital Discharge Management | Facility | 143 | 136 | $81.03 | $12K |
| 99233 Hospital E&M - Subsequent | Facility | 134 | 90 | $84.36 | $11K |
| 99204 Office E&M - New | Office | 118 | 118 | $110.16 | $13K |
| 95819 Neurologic | Facility | 36 | 35 | $41.22 | $1,484 |
| 95819 Neurologic | Office | 33 | 33 | $285.75 | $9,430 |
| 99213 Office E&M - Established | Office | 26 | 19 | $56.28 | $1,463 |
By year: 2022 $355K for 4,731 services; 2023 $343K for 4,352 services; 2024 $317K for 4,457 services.
Medicare prescription drug claims, 2024
In 2024, the drug Syed A Shah prescribed most often to Medicare patients was Zonisamide, with 383 prescriptions and refills. In total Syed A Shah wrote 8,053 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Zonisamide Generic | 383 | 722 | 123 | $19K |
| Levetiracetam Generic | 363 | 584 | 73 | $11K |
| Carbidopa-Levodopa Carbidopa/Levodopa | 357 | 659 | 113 | $11K |
| Lamotrigine Generic | 339 | 479 | 68 | $5,864 |
| Gabapentin Generic | 300 | 532 | 85 | $6,097 |
| Clopidogrel Clopidogrel Bisulfate | 278 | 581 | 91 | $2,650 |
| Memantine Hcl Generic | 225 | 451 | 72 | $8,397 |
| Duloxetine Hcl Generic | 216 | 411 | 77 | $6,557 |
| Phenytoin Sodium Extended Generic | 207 | 330 | 53 | $6,224 |
| Sertraline Hcl Generic | 188 | 375 | 61 | $2,236 |
| Quetiapine Fumarate Generic | 180 | 310 | 50 | $6,510 |
| Carbamazepine Generic | 178 | 258 | 72 | $7,327 |
| Donepezil Hcl Generic | 168 | 328 | 61 | $3,026 |
| Topiramate Generic | 165 | 288 | 44 | $2,758 |
| Atorvastatin Calcium Generic | 164 | 381 | 74 | $1,341 |
Brand drugs: 714 claims; generic drugs: 7,238 claims; opioid claims: 58.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Syed A Shah $1,214 ($1,214 in general payments such as food, travel and fees) from 18 companies. The largest payer was Jazz Pharmaceuticals Inc. with $364.
| Company | Payments | Amount |
|---|---|---|
| Jazz Pharmaceuticals Inc. JAZZ | 13 | $364 |
| Neurocrine BioSciences, Inc. NBIX | 7 | $132 |
| Pfizer Inc. PFE | 6 | $122 |
| Argenx US, Inc. ARGX | 6 | $113 |
| Novartis Pharmaceuticals Corporation NVS | 3 | $71.13 |
| Biogen, Inc. BIIB | 3 | $69.28 |
| Merz Pharmaceuticals, LLC | 4 | $60.73 |
| Abbvie Inc. ABBV | 2 | $46.31 |
| TG Therapeutics, Inc. TGTX | 2 | $45.51 |
| UCB, Inc. UCB.BR | 2 | $33.97 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.